Sign in

CIK 0000949858 · Non-accelerated filer<br>Smaller reporting company

ACHIEVE LIFE SCIENCES, INC.

Sign in to watch
Ticker
ACHV
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
954343413
Phone
425-686-1500
Business address
22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
Former names
ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
  1. SC 13D/A Stake Beneficial Ownership Report
  2. 8-K Event Benefit plan blackout
  3. SC 13G/A Stake Amended Statement of Ownership
  4. 4 Insider Changes in Ownership
  5. EFFECT Other Notice of Effectiveness
  6. EFFECT Other Notice of Effectiveness
  7. EFFECT Other Notice of Effectiveness
  8. EFFECT Other Notice of Effectiveness
  9. EFFECT Other Notice of Effectiveness
  10. EFFECT Other Notice of Effectiveness
  11. POS AM Other Post-effective Amendment for Registration Statement
  12. POS AM Other Post-effective Amendment for Registration Statement
  13. POS AM Other Post-effective Amendment for Registration Statement
  14. POS AM Other Post-effective Amendment for Registration Statement
  15. POS AM Other Post-effective Amendment for Registration Statement
  16. POS AM Other Post-effective Amendment for Registration Statement
  17. POS AM Other Post-effective Amendment for Registration Statement
  18. POS AM Other Post-effective Amendment for Registration Statement
  19. POS AM Other Post-effective Amendment for Registration Statement
  20. 8-K Event Regulation FD disclosure

Page 52 of 68 · 1,358 filings